Chinese radiotherapy firm to buy former-NAS breast brachytherapy technology
This article was originally published in Clinica
Huiheng Medical is to introduce the ClearPath breast brachytherapy system, a technology originally developed by the now bankrupt US company North American Scientific (NAS), to the Chinese market. The company also added that it looking to buy other technologies to launch in China.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.